BHVN NYSE
Biohaven Ltd.
1W: -8.8%
1M: -22.5%
3M: -27.3%
YTD: -22.6%
1Y: -47.6%
3Y: -38.4%
$9.02
+0.62 (+7.45%)
Weekly Expected Move ±8.4%
$7
$8
$9
$9
$10
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$888.2M
52W Range7.48-18.566
Volume1,210,868
Avg Volume2,133,180
Beta3.31
Dividend—
Analyst Ratings
Company Info
CEOVladimir Coric
Employees256
SectorHealthcare
IndustryBiotechnology
IPO Date2022-09-23
Websitebiohaven.com
215 Church Street
New Haven, CT 06510
US
New Haven, CT 06510
US
203 404 0410
About Biohaven Ltd.
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Mehta Kishan | A-Award | 68,693 | $9.61 | 2026-04-28 |
| Bailey Gregory | A-Award | 68,693 | $9.61 | 2026-04-28 |
| Heffernan Michael Th | A-Award | 68,693 | $9.61 | 2026-04-28 |
| Antonijevic Irina | A-Award | 68,693 | $9.61 | 2026-04-28 |
| CHILDS JOHN W | A-Award | 68,693 | $9.61 | 2026-04-28 |